Skip to content

Evaluation of the bioavailability of bioactive wheat bran components

Evaluation of the bioavailability of bioactive wheat bran components

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN09560399
Enrollment
14
Registered
2008-12-04
Start date
2006-04-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic diseases, particularly cardiovascular disease and cancers Not Applicable Chronic diseases

Interventions

1. Test-meal 1: 50 g wheat bran boiled in water with sugar 2. Test-meal 2: 50 g wheat aleurone boiled in water with sugar 3. Control-meal: 50 g refined wheat product Test and control meals were balan

Sponsors

European Commission (Belgium)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy 18 - 40 year old men and women with Body Mass Index (BMI) between 18 and 30 kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Smokers 2. Individuals with diabetes 3. Pre-existing chronic disease 4. On any prescription medicine 5. Individuals who regularly take any vitamin or mineral supplement or did so in the 6 months prior to the study 6. Gluten or wheat intolerant individuals 7. Pregnant or lactating women 8. Individuals who have given blood to the Blood Transfusion Service (BTS) in the 6 months prior to the study

Design outcomes

Primary

MeasureTime frame
1. Changes in plasma betaine, choline, folate, tocopherols and ferulic acid attributable to treatments, measured at baseline, 0.5 hours, 1 hour, 2 hours and 3 hours post-meal 2. Changes in urinary ferulic acid attributable to treatments, measured at baseline, 0.5 hours, 1 hour, 2 hours, 3 hours and 4 hours post-meal

Secondary

MeasureTime frame
1. Changes in plasma antioxidant activity attributable to treatments, measured at baseline, 0.5 hours, 1 hour, 2 hours and 3 hours post-meal 2. Changes in urinary antioxidant activity and phenolic activity attributable to treatments, measured at baseline, 0.5 hours, 1 hour, 2 hours, 3 hours and 4 hours post-meal

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026